Evaluations of in vivo and in vitro Dosimetry and Metabolic Biotransformation of the Hexafluoropropylene Oxide Homologue HFPO-TeA, an Emerging Per-and Polyfluoroalkyl Substance (PFAS)
Version 2 2022-11-15, 14:46Version 2 2022-11-15, 14:46
Version 1 2022-11-14, 17:23Version 1 2022-11-14, 17:23
presentation
posted on 2022-11-15, 14:46authored byDenise MacMillan, Aero Renyer, Marci
G. Smeltz, Matthew Phillips, Krishna Ravindra, Michael DeVito, Michael Hughes, Leah Wehmas, Barbara Wetmore
Presentation to SETAC in Pittsburgh, PA on Nov. 13-17, 2022